Application of Continuous Glucose Monitoring for Diabetes Detection
DOI:
https://doi.org/10.62051/wpmypn26Keywords:
diabetes; CGM system; optical.Abstract
Diabetes is a serious chronic disease characterized by high blood glucose. The prevalence of diabetes is very high in the whole world. If isn’t monitored and unmanaged, diabetes can lead to many severe health complications such as heart disease, stroke and kidney disease. Implantable continuous glucose monitoring (CGM) system is the current technique for monitoring the concentration of blood glucose for diabetes patients. There were two common types of implantable CGM in the market, which were electrochemical and optical. Electrochemical CGM systems were developed earlier and used in the market. Only one optical CGM system was used in the market, and many others are still in development. However, optical CGM has more benefits for diabetes patients. This research will show how electrochemical and optical work in the CGM system. It will describe the advantages of the optical CGM system, by comparing it with the electrochemical CGM systems. There are two pieces of research about testing the safety and accuracy of the optical CGM system. It would show how optical CGM systems have a high potential in the area of diabetes. Also, it will describe how optical CGM systems have a high possibility of becoming the future trend in CGM systems.
Downloads
References
[1] Malik J, Kim S, Seo J M, et al. Minimally invasive implant type electromagnetic biosensor for continuous glucose monitoring system: In vivo evaluation. IEEE Transactions on Biomedical Engineering, 2022, 70(3): 1000-1011.
[2] Freckmann G. Basics and use of continuous glucose monitoring (CGM) in diabetes therapy. Journal of Laboratory Medicine, 2020, 44(2): 71-79.
[3] Lee I, Probst D, Klonoff D, et al. Continuous glucose monitoring systems-Current status and future perspectives of the flagship technologies in biosensor research. Biosensors and Bioelectronics, 2021, 181: 113054.
[4] Ahmed I, Jiang N, Shao X, et al. Recent advances in optical sensors for continuous glucose monitoring. Sensors & Diagnostics, 2022, 1(6): 1098-1125.
[5] Deiss D, Irace C, Carlson G, et al. Real-world safety of an implantable continuous glucose sensor over multiple cycles of use: a post-market registry study. Diabetes Technology & Therapeutics, 2020, 22(1): 48-52.
[6] Garg S K, Liljenquist D, Bode B, et al. Evaluation of accuracy and safety of the next-generation up to 180-day long-term implantable eversense continuous glucose monitoring system: the PROMISE study. Diabetes Technology & Therapeutics, 2022, 24(2): 84-92.
Downloads
Published
Conference Proceedings Volume
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.







